SCHEMBL15065071

SCHEMBL15065071

CCCCC(CC)c1cc(-c2cc(C(CC)CCCC)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
ATM Q13315 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
XBP1 P17861 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2C9 P11712 5/20 0.38
CYP2C19 P33261 5/20 0.38
CYP1A2 P05177 4/20 0.38
TSHR P16473 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.36
NR5A2 O00482 1/20 0.35
NR5A1 Q13285 1/20 0.35
CA2 P00918 3/20 0.35
CA1 P00915 2/20 0.35
ALOX15 P16050 3/20 0.35
HPN P05981 1/20 0.35
MAPT P10636 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35
IDH1 O75874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065448 0.91 CYP2C9 (0.37) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL17781754 0.91 CYP2C9 (0.39) GAAATMNPSR1CYP2C9CYP2C19
SCHEMBL17453957 0.86 NR1I2 (0.42) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL17472906 0.86 NR1I2 (0.42) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL1116346 0.86 NR1I2 (0.42) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL15065029 0.84 CYP2C9 (0.41) GAAATMNPSR1CYP2C9CYP2C19
SCHEMBL15064994 0.83 CYP1A2 (0.40) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL2292908 0.82 NPSR1 (0.41) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL15064911 0.79 CYP1A2 (0.39) GAAATMNPSR1XBP1L3MBTL1
SCHEMBL822427 0.78 CA2 (0.52) GAAATMNPSR1L3MBTL1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797938-B1 METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2016-06-01 EP disclosed
EP-2797938-A1 METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2014-11-05 EP disclosed
US-8841474-B2 Process for preparing 6-chlorodibenzo[D,F][1,3,2]dioxaphosphepin BASF SE (DE) 2014-09-23 US disclosed
US-20130172596-A1 PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2013-07-04 US disclosed
WO-2013098371-A1 METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2013-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172596-A1 PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN DCPS, PLCB3, DDT GAA 2245/4885ATM 3345/4885NPSR1 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.